Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 33ABBVIE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

US Patent Number : 9139536

Drug Substance Claim :

Drug Product Claim :

Application Number : 206619

Patent Use Code : U-1753

Delist Requested :

Patent Use Description : TREATMENT OF HCV INFEC...

Patent Expiration Date : 2028-11-09

Abbvie Company Banner

02

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

US Patent Number : 8466159

Drug Substance Claim :

Drug Product Claim :

Application Number : 206619

Patent Use Code : U-1637

Delist Requested :

Patent Use Description : TREATMENT OF HCV INFEC...

Patent Expiration Date : 2032-09-04

Abbvie Company Banner

03

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

US Patent Number : 8501238

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206619

Patent Use Code : U-1636

Delist Requested :

Patent Use Description : USE OF DASABUVIR TO IN...

Patent Expiration Date : 2028-12-19

Abbvie Company Banner

04

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

US Patent Number : 9629841

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206619

Patent Use Code : U-1753

Delist Requested :

Patent Use Description : TREATMENT OF HCV INFEC...

Patent Expiration Date : 2033-10-18

Abbvie Company Banner

05

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

US Patent Number : 9139536

Drug Substance Claim :

Drug Product Claim :

Application Number : 208624

Patent Use Code : U-1753

Delist Requested :

Patent Use Description : TREATMENT OF HCV INFEC...

Patent Expiration Date : 2028-11-09

Abbvie Company Banner

06

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

US Patent Number : 9044480

Drug Substance Claim :

Drug Product Claim :

Application Number : 208624

Patent Use Code : U-1638

Delist Requested :

Patent Use Description : TREATMENT OF HCV INFEC...

Patent Expiration Date : 2031-04-10

Abbvie Company Banner

07

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

US Patent Number : 8466159

Drug Substance Claim :

Drug Product Claim :

Application Number : 208624

Patent Use Code : U-1637

Delist Requested :

Patent Use Description : TREATMENT OF HCV INFEC...

Patent Expiration Date : 2032-09-04

Abbvie Company Banner

08

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

US Patent Number : 9006387

Drug Substance Claim :

Drug Product Claim :

Application Number : 208624

Patent Use Code : U-1687

Delist Requested :

Patent Use Description : TREATMENT OF HCV INFEC...

Patent Expiration Date : 2030-06-10

Abbvie Company Banner

09

DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

US Patent Number : 8501238

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208624

Patent Use Code : U-1636

Delist Requested :

Patent Use Description : USE OF DASABUVIR TO IN...

Patent Expiration Date : 2028-09-17

Abbvie Company Banner

10

DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

US Patent Number : 8642538

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206619

Patent Use Code : U-1638

Delist Requested :

Patent Use Description : TREATMENT OF HCV INFEC...

Patent Expiration Date : 2029-09-10

Abbvie Company Banner